Carboxyterminal protein processing in health and disease: Key actors and emerging technologies

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4497-4504

  Petrera, Agnese ^a   Lai, Zon Weng ^a   Schilling, Oliver ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

biomarkers; Carboxypeptidase; degradomics; peptidase; protease; proteolysis

Indexed keywords

CARBOXYPEPTIDASE; CYSTEINE PROTEINASE; SERINE CARBOXYPEPTIDASE;

CARCINOGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL FUNCTION; DEGENERATIVE DISEASE; DISEASES; EMBRYO DEVELOPMENT; HEALTH; HUMAN; MASS SPECTROMETRY; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEOMICS; REVIEW; GENETICS; METABOLISM; NERVOUS SYSTEM; PROCEDURES; SIGNAL TRANSDUCTION; TRENDS;

CARBOXYPEPTIDASES; CARDIOVASCULAR SYSTEM; HUMANS; NERVOUS SYSTEM; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84908889440     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr5005746     Document Type: Review

References (72)

1. Tanco, S. Proteome-derived peptide libraries to study the substrate specificity profiles of carboxypeptidases Mol. Cell. Proteomics 2013, 12, 2096-110
2. Vendrell, J. Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties Biochim. Biophys. Acta 2000, 1477, 284-98
3. Fernandez, D. Progress in metallocarboxypeptidases and their small molecular weight inhibitors Biochimie 2010, 92, 1484-500
4. Reznik, S. E.; Fricker, L. D. Carboxypeptidases from a to z: implications in embryonic development and Wnt binding Cell. Mol. Life Sci. 2001, 58, 1790-804
5. Marx, P. F. Thrombin-activatable fibrinolysis inhibitor Curr. Med. Chem. 2004, 11, 2335-48
6. Pejler, G. Novel insights into the biological function of mast cell carboxypeptidase A Trends Immunol. 2009, 30, 401-8
7. Rogowski, K. A family of protein-deglutamylating enzymes associated with neurodegeneration Cell 2010, 143, 564-78
8. Berezniuk, I. Cytosolic carboxypeptidase 5 removes alpha-and gamma-linked glutamates from tubulin J. Biol. Chem. 2013, 288, 30445-53
9. Berezniuk, I. Cytosolic carboxypeptidase 1 is involved in processing alpha-and beta-tubulin J. Biol. Chem. 2012, 287, 6503-17
10. Lipscomb, W. N.; Strater, N. Recent advances in zinc enzymology Chem. Rev. 1996, 96, 2375-2434
11. Keil, C. Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain J. Mol. Biol. 2007, 366, 504-16
12. Reverter, D. Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity J. Mol. Biol. 2004, 338, 257-69
13. Marx, P. F. Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation Blood 2008, 112, 2803-9
14. Warner, F. J. Angiotensin-converting enzyme-2: a molecular and cellular perspective Cell. Mol. Life Sci. 2004, 61, 2704-13
15. Acharya, K. R. Ace revisited: a new target for structure-based drug design Nat. Rev. Drug Discovery 2003, 2, 891-902
16. Li, W. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 2003, 426, 450-4
17. Rajasekaran, A. K. Is prostate-specific membrane antigen a multifunctional protein? Am. J. Physiol.: Cell Physiol. 2005, 288, C975-81
18. Rudenko, G. Three-dimensional structure of the human protective protein: structure of the precursor form suggests a complex activation mechanism Structure 1995, 3, 1249-59
19. Remington, S. J. Serine carboxypeptidases: a new and versatile family of enzymes Curr. Opin. Biotechnol. 1993, 4, 462-8
20. Soisson, S. M. Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase BMC Struct. Biol. 2010, 10, 16
21. Holmquist, M. Alpha/beta-hydrolase fold enzymes: structures, functions and mechanisms Curr. Protein Pept. Sci. 2000, 1, 209-35
22. Breddam, K. Serine carboxypeptidases-a review Carlsberg Res. Commun. 1986, 51, 83-128
23. Odya, C. E. Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney J. Biol. Chem. 1978, 253, 5927-31
24. Cooper, A.; Bussey, H. Characterization of the yeast Kex1 gene-product-a carboxypeptidase involved in processing secreted precursor proteins Mol. Cell. Biol. 1989, 9, 2706-2714
25. Hinek, A. Lysosomal sialidase (neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly J. Biol. Chem. 2006, 281, 3698-710
26. Pshezhetsky, A. V.; Hinek, A. Serine carboxypeptidases in regulation of vasoconstriction and elastogenesis Trends Cardiovasc. Med. 2009, 19, 11-7
27. DAzzo, A. Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man Proc. Natl. Acad. Sci. U.S.A. 1982, 79, 4535-9
28. Menard, R.; Sulea, T. Cathepsin X. In Handbook of Proteolytic Enzymes; Barrett, A. J.; Rawlings, N. D.; Woessner, J. F., Eds.; Academic: Oxford, 2004; Vol. 2, pp 1113-1116.
29. Mort, J. S. Cathepsin B. In Handbook of Proteolytic Enzymes; Barrett, A. J.; Rawlings, N. D.; Woessner, J. F., Eds.; Academic: Oxford, 2004; Vol. 2, pp 1079-1086.
30. Reiser, J. Specialized roles for cysteine cathepsins in health and disease J. Clin. Invest. 2010, 120, 3421-31
31. Vasiljeva, O. Emerging roles of cysteine cathepsins in disease and their potential as drug targets Curr. Pharm. Des 2007, 13, 387-403
32. Barinka, C. Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer Curr. Med. Chem. 2012, 19, 856-70
33. Sugimoto, Y. The therapeutic potential of a novel PSMA antibody and its IL-2 conjugate in prostate cancer Anticancer Res. 2014, 34, 89-97
34. Witte, J. S. Genomewide scan for prostate cancer-aggressiveness loci Am. J. Hum. Genet. 2000, 67, 92-9
35. Huang, H. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells Cancer Res. 1999, 59, 2981-8
36. Kayashima, T. The novel imprinted carboxypeptidase A4 gene (CPA4) in the 7q32 imprinting domain Hum. Genet. 2003, 112, 220-6
37. Ross, P. L. Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer BMC Cancer 2009, 9, 69
38. Tanco, S. Characterization of the substrate specificity of human carboxypeptidase A4 and implications for a role in extracellular peptide processing J. Biol. Chem. 2010, 285, 18385-96
39. Kalinina, E. A novel subfamily of mouse cytosolic carboxypeptidases FASEB J. 2007, 21, 836-50
40. Rodriguez de la Vega, M. Nna1-like proteins are active metallocarboxypeptidases of a new and diverse M14 subfamily FASEB J. 2007, 21, 851-65
41. Fernandez-Gonzalez, A. Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene, Nna1 Science 2002, 295, 1904-6
42. Mullen, R. J. Purkinje cell degeneration, a new neurological mutation in the mouse Proc. Natl. Acad. Sci. U.S.A. 1976, 73, 208-12
43. Chakrabarti, L. The zinc-binding domain of Nna1 is required to prevent retinal photoreceptor loss and cerebellar ataxia in Purkinje cell degeneration (pcd) mice Vision Res. 2008, 48, 1999-2005
44. Wang, T. The carboxypeptidase-like substrate-binding site in Nna1 is essential for the rescue of the Purkinje cell degeneration (pcd) phenotype Mol. Cell. Neurosci. 2006, 33, 200-13
45. Chakrabarti, L. Mitochondrial dysfunction in NnaD mutant flies and Purkinje cell degeneration mice reveals a role for Nna proteins in neuronal bioenergetics Neuron 2010, 66, 835-47
46. Harris, A. Regenerating motor neurons express Nna1, a novel ATP/GTP-binding protein related to zinc carboxypeptidases Mol. Cell. Neurosci. 2000, 16, 578-96
47. Berezniuk, I. Quantitative peptidomics of Purkinje cell degeneration mice PLoS One 2013, 8, e60981
48. Seyrantepe, V. Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1 Circulation 2008, 117, 1973-81
49. Pan, X. Serine carboxypeptidase SCPEP1 and cathepsin A play complementary roles in regulation of vasoconstriction via inactivation of endothelin-1 PLoS Genet 2014, 10, e1004146
50. Ruf, S. Novel beta-amino acid derivatives as inhibitors of cathepsin A J. Med. Chem. 2012, 55, 7636-49
51. Ruf, S. Inhibition of CatA: an emerging strategy for the treatment of heart failure Future Med. Chem. 2013, 5, 399-409
52. Sevenich, L. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 2497-502
53. Sriranganadane, D. Identification of novel secreted proteases during extracellular proteolysis by dermatophytes at acidic pH Proteomics 2011, 11, 4422-4433
54. Lai, Z. W. Angiotensin-converting enzyme 2 ectodomain shedding cleavage-site identification: determinants and constraints Biochemistry 2011, 50, 5182-5194
55. Sechi, S.; Chait, B. T. A method to define the carboxyl terminal of proteins Anal. Chem. 2000, 72, 3374-8
56. Dormeyer, W. Targeted analysis of protein termini J. Proteome Res. 2007, 6, 4634-45
57. Gorman, J. J.; Shiell, B. J. Isolation of carboxyl-termini and blocked amino-termini of viral proteins by high-performance cation-exchange chromatography J. Chromatogr. 1993, 646, 193-205
58. Villanueva, J. Differential exoprotease activities confer tumor-specific serum peptidome patterns J. Clin. Invest. 2006, 116, 271-84
59. Villanueva, J. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry Anal. Chem. 2004, 76, 1560-70
60. Villanueva, J. Correcting common errors in identifying cancer-specific serum peptide signatures J. Proteome Res. 2005, 4, 1060-72
61. Che, F. Y. Peptidomics of Cpe fat/fat mouse hypothalamus: effect of food deprivation and exercise on peptide levels J. Biol. Chem. 2005, 280, 4451-61
62. Zhang, X. Peptidomics of Cpe(fat/fat) mouse brain regions: implications for neuropeptide processing J. Neurochem. 2008, 107, 1596-613
63. Schilling, O. Proteome-wide analysis of protein carboxy termini: C terminomics Nat. Methods 2010, 7, 508-11
64. Schilling, O. Identification and relative quantification of native and proteolytically generated protein C-termini from complex proteomes: C-terminome analysis Methods Mol. Biol. 2011, 781, 59-69
65. Van Damme, P. Complementary positional proteomics for screening substrates of endo-and exoproteases Nat. Methods 2010, 7, 512-5
66. Patterson, D. H. C-Terminal ladder sequencing via matrix-assisted laser desorption mass spectrometry coupled with carboxypeptidase Y time-dependent and concentration-dependent digestions Anal. Chem. 1995, 67, 3971-8
67. Samyn, B. A new method for C-terminal sequence analysis in the proteomic era Nat. Methods 2005, 2, 193-200
68. Samyn, B. A method for C-terminal sequence analysis in the proteomic era (proteins cleaved with cyanogen bromide) Nat. Protoc. 2006, 1, 318-23
69. Miyazaki, K.; Tsugita, A. C-Terminal sequencing method for peptides and proteins by the reaction with a vapor of perfluoric acid in acetic anhydride Proteomics 2004, 4, 11-9
70. Miyazaki, K.; Tsugita, A. C-Terminal sequencing method for proteins in polyacrylamide gel by the reaction of acetic anhydride Proteomics 2006, 6, 2026-33
71. Kuyama, H. A simple and highly successful C-terminal sequence analysis of proteins by mass spectrometry Proteomics 2008, 8, 1539-50
72. Shahinian, H. Proteomic identification of protease cleavage sites: cell-biological and biomedical applications Expert Rev. Proteomics 2013, 10, 421-33